|
Mechanism5α-reductase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date20 Nov 2001 |
100 Clinical Results associated with Yu & Life Science Co Ltd.
0 Patents (Medical) associated with Yu & Life Science Co Ltd.
100 Deals associated with Yu & Life Science Co Ltd.
100 Translational Medicine associated with Yu & Life Science Co Ltd.